Pet positivity after 2 cycles of abvd is a risk factor in patients with early-stage favorable Hodgkin lymphoma treated in the phase 3 GHSG HD16 study - Fuchs, M.; Goergen, H.; Kobe, C.; Kuhnert, G.; Hitz, F.; Greil, R.; Sasse, S.; Topp, M. S.; Schaefer, E.; Hertenstein, B.; Soekler, M.; Vogelhuber, M.; et al. (ONCOLOGY RESEARCH AND TREATMENT, 2019)
CRIS-Team WoS Importer:2020-10-02